Ever wondered why some racial/ethnic communities have higher rates of disease and how they may respond differently to certain treatments?
Esteban Burchard, MD, MPH, spends a lot of time thinking about this. In fact, his lab is identifying the risk factors that predispose these communities to certain conditions and exploring how these new discoveries can lead to improved treatment.
Join our webinar as Dr. Burchard, Professor of Medicine and Biopharmaceutical Sciences at the University of California, San Francisco, discusses the role of ancestry in advancing socially responsible scientific research to precision medicine. Learn new research insights and incorporate them into your curriculum.
Esteban González Burchard, MD, MPH, is a physician-scientist with formal training and expertise in pulmonary medicine, epidemiology, molecular genetics, and genetic and clinical research. He has led a large research program focusing on minority children and gene-environment interactions since 2001.
Dr. Burchard serves as an advisor to the National Academy of Sciences of the U.S. Congress on gene-environment interactions. Dr. Burchard has expertise in the field of precision medicine and served on the Expert Panel for President Obama’s Precision Medicine Initiative.
He initiated and now directs four independent asthma studies in minority children. His team is taking a comprehensive approach to studying asthma and related phenotypes in minority children by focusing on genetic, social and environmental risk factors with the goal of creating innovative therapies and identifying targets for public health inventions.